Case number 1:10-cv-12079
Momenta Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals Industries Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 9, 2012 | 33 | Notice (Other) (3) |
| Jan 9, 2012 | 36 | Notice of Appearance (2) |
| Jan 9, 2012 | 38 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (25) |
| Jan 9, 2012 | 41 | Sur-Reply to Motion (8) |
| Jan 9, 2012 | 39 | Main Document (11) |
| Jan 9, 2012 | 1 | Exhibit A (2) |
| Jan 9, 2012 | 42 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (4) |
| Jan 9, 2012 | 47 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A (11) |
| Jan 9, 2012 | 52 | Motion for Miscellaneous Relief (3) |
| Jan 9, 2012 | 53 | Memorandum in Support of Motion (16) |
| Jan 9, 2012 | 54 | Declaration (12) |
| Jan 9, 2012 | 55 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 2 | Exhibit B (2) |
| Jan 9, 2012 | 3 | Exhibit C (3) |
| Jan 9, 2012 | 4 | Exhibit D (3) |
| Jan 9, 2012 | 5 | Exhibit E (3) |
| Jan 9, 2012 | 6 | Exhibit F (3) |
| Jan 9, 2012 | 7 | Exhibit G (3) |
| Jan 9, 2012 | 8 | Exhibit H (7) |
| Jan 9, 2012 | 9 | Exhibit I (3) |
| Jan 9, 2012 | 10 | Exhibit J (3) |
| Jan 9, 2012 | 62 | Main Document (4) |
| Jan 9, 2012 | 1 | Text of Proposed Order (1) |
| Jan 9, 2012 | 14 | Notice of Appearance (2) |
| Jan 9, 2012 | 15 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit Certification fo David M. Hashmall (3) |
| Jan 9, 2012 | 16 | Notice of Appearance (2) |
| Jan 9, 2012 | 17 | Corporate Disclosure Statement (3) |
| Jan 9, 2012 | 18 | Notice of Appearance (2) |
| Jan 9, 2012 | 19 | Stipulation (3) |
| Jan 9, 2012 | 24 | Notice of Appearance (2) |
| Jan 9, 2012 | 27 | Stipulation of Dismissal (4) |
| Jan 9, 2012 | 25 | Main Document (2) |
| Jan 9, 2012 | 1 | Text of Proposed Order (1) |
| Jan 9, 2012 | 29 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 28 | Opposition to Motion (14) |
| Jan 9, 2012 | 30 | Answer to Complaint (14) |
| Jan 9, 2012 | 30 | Counterclaim (14) |
| Jan 9, 2012 | 32 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (16) |
| Jan 9, 2012 | 33 | Notice (Other) (3) |
| Jan 9, 2012 | 36 | Notice of Appearance (2) |
| Jan 9, 2012 | 38 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (25) |
| Jan 9, 2012 | 39 | Main Document (11) |
| Jan 9, 2012 | 1 | Exhibit A (2) |
| Jan 9, 2012 | 42 | Main Document (3) |
| Jan 9, 2012 | 41 | Sur-Reply to Motion (8) |
| Jan 9, 2012 | 1 | Exhibit A (4) |
| Jan 9, 2012 | 47 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A (11) |
| Jan 9, 2012 | 52 | Motion for Miscellaneous Relief (3) |
| Jan 9, 2012 | 53 | Memorandum in Support of Motion (16) |
| Jan 9, 2012 | 54 | Declaration (12) |
| Jan 9, 2012 | 55 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 2 | Exhibit B (2) |
| Jan 9, 2012 | 3 | Exhibit C (3) |
| Jan 9, 2012 | 4 | Exhibit D (3) |
| Jan 9, 2012 | 5 | Exhibit E (3) |
| Jan 9, 2012 | 6 | Exhibit F (3) |
| Jan 9, 2012 | 7 | Exhibit G (3) |
| Jan 9, 2012 | 8 | Exhibit H (7) |
| Jan 9, 2012 | 9 | Exhibit I (3) |
| Jan 9, 2012 | 10 | Exhibit J (3) |
| Jan 9, 2012 | 62 | Main Document (4) |
| Jan 9, 2012 | 1 | Text of Proposed Order (1) |
| Jan 9, 2012 | 19 | Stipulation (3) |
| Jan 9, 2012 | 20 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (10) |
| Jan 9, 2012 | 21 | Memorandum in Support of Motion (12) |
| Jan 9, 2012 | 22 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 2 | Exhibit B (43) |
| Jan 9, 2012 | 3 | Exhibit C (20) |
| Jan 9, 2012 | 4 | Exhibit D (3) |
| Jan 9, 2012 | 5 | Exhibit E (2) |
| Jan 9, 2012 | 6 | Exhibit F (19) |
| Jan 9, 2012 | 7 | Exhibit G (23) |
| Jan 9, 2012 | 8 | Exhibit H (23) |
| Jan 9, 2012 | 23 | Certificate of Consultation pursuant to LR 7.1 (3) |
| Jan 9, 2012 | 26 | Main Document (2) |
| Jan 9, 2012 | 1 | Affidavit Affidavit of Thomas P. Steindler (2) |
| Jan 9, 2012 | 27 | Stipulation of Dismissal (4) |
| Jan 9, 2012 | 34 | Answer to Counterclaim (5) |
| Jan 9, 2012 | 31 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A - Proposed Reply Memorandum in Support of Plaintiffs Momenta Pharmaceu (23) |
| Jan 9, 2012 | 39 | Main Document (11) |
| Jan 9, 2012 | 1 | Exhibit A (2) |
| Jan 9, 2012 | 38 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (25) |
| Jan 9, 2012 | 44 | Memorandum in Support of Motion (12) |
| Jan 9, 2012 | 45 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 2 | Exhibit B (4) |
| Jan 9, 2012 | 47 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A (11) |
| Jan 9, 2012 | 56 | Opposition to Motion (15) |
| Jan 9, 2012 | 57 | Affidavit in Opposition to Motion (3) |
| Jan 9, 2012 | 58 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit 1 to the Declaration of Jessica Gan Lee (20) |
| Jan 9, 2012 | 2 | Exhibit 2 to the Declaration of Jessica Gan Lee (36) |
| Jan 9, 2012 | 3 | Exhibit 3 to the Declaration of Jessica Gan Lee (5) |
| Jan 9, 2012 | 4 | Exhibit 4 to the Declaration of Jessica Gan Lee (5) |
| Jan 9, 2012 | 61 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A (12) |
| Jan 9, 2012 | 2 | Text of Proposed Order (2) |
| Jan 9, 2012 | 14 | Notice of Appearance (2) |
| Jan 9, 2012 | 15 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit Certification fo David M. Hashmall (3) |
| Jan 9, 2012 | 16 | Notice of Appearance (2) |
| Jan 9, 2012 | 18 | Notice of Appearance (2) |
| Jan 9, 2012 | 19 | Stipulation (3) |
| Jan 9, 2012 | 24 | Notice of Appearance (2) |
| Jan 9, 2012 | 25 | Main Document (2) |
| Jan 9, 2012 | 1 | Text of Proposed Order (1) |
| Jan 9, 2012 | 27 | Stipulation of Dismissal (4) |
| Jan 9, 2012 | 28 | Opposition to Motion (14) |
| Jan 9, 2012 | 29 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 14 | Notice of Appearance (2) |
| Jan 9, 2012 | 15 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit Certification fo David M. Hashmall (3) |
| Jan 9, 2012 | 16 | Notice of Appearance (2) |
| Jan 9, 2012 | 17 | Corporate Disclosure Statement (3) |
| Jan 9, 2012 | 19 | Stipulation (3) |
| Jan 9, 2012 | 18 | Notice of Appearance (2) |
| Jan 9, 2012 | 24 | Notice of Appearance (2) |
| Jan 9, 2012 | 25 | Main Document (2) |
| Jan 9, 2012 | 27 | Stipulation of Dismissal (4) |
| Jan 9, 2012 | 1 | Text of Proposed Order (1) |
| Jan 9, 2012 | 28 | Opposition to Motion (14) |
| Jan 9, 2012 | 29 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 30 | Answer to Complaint (14) |
| Jan 9, 2012 | 30 | Counterclaim (14) |
| Jan 9, 2012 | 32 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (16) |
| Jan 9, 2012 | 58 | Main Document (3) |
| Jan 9, 2012 | 56 | Opposition to Motion (15) |
| Jan 9, 2012 | 26 | Main Document (2) |
| Jan 9, 2012 | 23 | Certificate of Consultation pursuant to LR 7.1 (3) |
| Jan 9, 2012 | 3 | Corporate Disclosure Statement (3) |
| Jan 9, 2012 | 39 | Main Document (11) |
| Jan 9, 2012 | 45 | Main Document (3) |
| Jan 9, 2012 | 20 | Main Document (3) |
| Jan 9, 2012 | 21 | Memorandum in Support of Motion (12) |
| Jan 9, 2012 | 1 | Main Document (12) |
| Jan 9, 2012 | 19 | Stipulation (3) |
| Jan 9, 2012 | 38 | Main Document (3) |
| Jan 9, 2012 | 11 | Notice of Appearance (2) |
| Jan 9, 2012 | 61 | Main Document (4) |
| Jan 9, 2012 | 47 | Main Document (4) |
| Jan 9, 2012 | 22 | Main Document (3) |
| Jan 9, 2012 | 57 | Affidavit in Opposition to Motion (3) |
| Jan 9, 2012 | 51 | Notice of Appearance (2) |
| Jan 9, 2012 | 34 | Answer to Counterclaim (5) |
| Jan 9, 2012 | 31 | Main Document (4) |
| Jan 9, 2012 | 50 | Notice of Appearance (2) |
| Jan 9, 2012 | 44 | Memorandum in Support of Motion (12) |
| Jan 9, 2012 | 27 | Stipulation of Dismissal (4) |
| Jan 9, 2012 | 10 | Notice of Appearance (1) |
| Jan 9, 2012 | 45 | Main Document (3) |
| Jan 9, 2012 | 47 | Main Document (4) |
| Jan 9, 2012 | 56 | Opposition to Motion (15) |
| Jan 9, 2012 | 57 | Affidavit in Opposition to Motion (3) |
| Jan 9, 2012 | 1 | Exhibit 1 to the Declaration of Jessica Gan Lee (20) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 1 | Exhibit A - Proposed Reply Memorandum in Support of Plaintiffs Momenta Pharmaceu (23) |
| Jan 9, 2012 | 1 | Exhibit A (12) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 1 | Exhibit A (11) |
| Jan 9, 2012 | 1 | Exhibit A (11) |
| Jan 9, 2012 | 1 | Affidavit Affidavit of Thomas P. Steindler (2) |
| Jan 9, 2012 | 1 | Exhibit A (10) |
| Jan 9, 2012 | 2 | Exhibit B (4) |
| Jan 9, 2012 | 2 | Exhibit 2 to the Declaration of Jessica Gan Lee (36) |
| Jan 9, 2012 | 1 | Exhibit A1 '886 Patent (21) |
| Jan 9, 2012 | 1 | Exhibit A (25) |
| Jan 9, 2012 | 1 | Exhibit A (2) |
| Jan 9, 2012 | 2 | Text of Proposed Order (2) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 2 | Exhibit B (4) |
| Jan 9, 2012 | 3 | Exhibit 3 to the Declaration of Jessica Gan Lee (5) |
| Jan 9, 2012 | 2 | Exhibit B (43) |
| Jan 9, 2012 | 2 | Exhibit A2 '886 Patent (9) |
| Jan 9, 2012 | 3 | Exhibit A3 '886 Patent (9) |
| Jan 9, 2012 | 4 | Exhibit A4 '886 Patent (10) |
| Jan 9, 2012 | 3 | Exhibit C (20) |
| Jan 9, 2012 | 4 | Exhibit D (3) |
| Jan 9, 2012 | 4 | Exhibit 4 to the Declaration of Jessica Gan Lee (5) |
| Jan 9, 2012 | 5 | Exhibit E (2) |
| Jan 9, 2012 | 5 | Exhibit A5 '886 Patent (9) |
| Jan 9, 2012 | 6 | Exhibit F (19) |
| Jan 9, 2012 | 6 | Exhibit B1 '466 Patent (11) |
| Jan 9, 2012 | 7 | Exhibit G (23) |
| Jan 9, 2012 | 7 | Exhibit B2 '466 Patent (7) |
| Jan 9, 2012 | 8 | Exhibit H (23) |
| Jan 9, 2012 | 8 | Exhibit B3 '466 Patent (5) |
| Jan 9, 2012 | 9 | Exhibit C Teva's Q4 Earnings Conference Transcript (23) |
| Jan 9, 2012 | 61 | Main Document (4) |
| Jan 9, 2012 | 10 | Exhibit D Teva's Q1 2010 Earnings Call (20) |
| Jan 9, 2012 | 1 | Exhibit A (12) |
| Jan 9, 2012 | 11 | Exhibit E Teva's Press Release (3) |
| Jan 9, 2012 | 12 | Exhibit F Teva's Q2 2010 Earnings Conference Transcript (23) |
| Jan 9, 2012 | 2 | Text of Proposed Order (2) |
| Jan 9, 2012 | 13 | Exhibit G Teva Article (2) |
| Jan 9, 2012 | 14 | Exhibit H Teva's Q3 2010 Earnings Conference Transcript (19) |
| Jan 9, 2012 | 15 | Civil Cover Sheet (2) |
| Jan 9, 2012 | 16 | Category Form (1) |
| Jan 9, 2012 | 58 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit 1 to the Declaration of Jessica Gan Lee (20) |
| Jan 9, 2012 | 2 | Exhibit 2 to the Declaration of Jessica Gan Lee (36) |
| Jan 9, 2012 | 3 | Exhibit 3 to the Declaration of Jessica Gan Lee (5) |
| Jan 9, 2012 | 4 | Exhibit 4 to the Declaration of Jessica Gan Lee (5) |
| Jan 9, 2012 | 1 | Main Document (12) |
| Jan 9, 2012 | 1 | Exhibit A1 '886 Patent (21) |
| Jan 9, 2012 | 2 | Exhibit A2 '886 Patent (9) |
| Jan 9, 2012 | 3 | Exhibit A3 '886 Patent (9) |
| Jan 9, 2012 | 3 | Corporate Disclosure Statement (3) |
| Jan 9, 2012 | 4 | Exhibit A4 '886 Patent (10) |
| Jan 9, 2012 | 5 | Exhibit A5 '886 Patent (9) |
| Jan 9, 2012 | 6 | Exhibit B1 '466 Patent (11) |
| Jan 9, 2012 | 7 | Exhibit B2 '466 Patent (7) |
| Jan 9, 2012 | 8 | Exhibit B3 '466 Patent (5) |
| Jan 9, 2012 | 9 | Exhibit C Teva's Q4 Earnings Conference Transcript (23) |
| Jan 9, 2012 | 10 | Exhibit D Teva's Q1 2010 Earnings Call (20) |
| Jan 9, 2012 | 11 | Exhibit E Teva's Press Release (3) |
| Jan 9, 2012 | 12 | Exhibit F Teva's Q2 2010 Earnings Conference Transcript (23) |
| Jan 9, 2012 | 13 | Exhibit G Teva Article (2) |
| Jan 9, 2012 | 14 | Exhibit H Teva's Q3 2010 Earnings Conference Transcript (19) |
| Jan 9, 2012 | 15 | Civil Cover Sheet (2) |
| Jan 9, 2012 | 16 | Category Form (1) |
| Jan 9, 2012 | 10 | Notice of Appearance (1) |
| Jan 9, 2012 | 11 | Notice of Appearance (2) |
| Jan 9, 2012 | 2 | Corporate Disclosure Statement (3) |
| Jan 9, 2012 | 1 | Main Document (12) |
| Jan 9, 2012 | 1 | Exhibit A1 '886 Patent (21) |
| Jan 9, 2012 | 2 | Exhibit A2 '886 Patent (9) |
| Jan 9, 2012 | 3 | Exhibit A3 '886 Patent (9) |
| Jan 9, 2012 | 4 | Exhibit A4 '886 Patent (10) |
| Jan 9, 2012 | 5 | Exhibit A5 '886 Patent (9) |
| Jan 9, 2012 | 6 | Exhibit B1 '466 Patent (11) |
| Jan 9, 2012 | 7 | Exhibit B2 '466 Patent (7) |
| Jan 9, 2012 | 8 | Exhibit B3 '466 Patent (5) |
| Jan 9, 2012 | 9 | Exhibit C Teva's Q4 Earnings Conference Transcript (23) |
| Jan 9, 2012 | 10 | Exhibit D Teva's Q1 2010 Earnings Call (20) |
| Jan 9, 2012 | 11 | Exhibit E Teva's Press Release (3) |
| Jan 9, 2012 | 12 | Exhibit F Teva's Q2 2010 Earnings Conference Transcript (23) |
| Jan 9, 2012 | 13 | Exhibit G Teva Article (2) |
| Jan 9, 2012 | 14 | Exhibit H Teva's Q3 2010 Earnings Conference Transcript (19) |
| Jan 9, 2012 | 15 | Civil Cover Sheet (2) |
| Jan 9, 2012 | 16 | Category Form (1) |
| Jan 9, 2012 | 5 | Notice of Appearance (2) |
| Jan 9, 2012 | 6 | Notice of Appearance (2) |
| Jan 9, 2012 | 19 | Stipulation (3) |
| Jan 9, 2012 | 20 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (10) |
| Jan 9, 2012 | 21 | Memorandum in Support of Motion (12) |
| Jan 9, 2012 | 22 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 2 | Exhibit B (43) |
| Jan 9, 2012 | 3 | Exhibit C (20) |
| Jan 9, 2012 | 4 | Exhibit D (3) |
| Jan 9, 2012 | 5 | Exhibit E (2) |
| Jan 9, 2012 | 6 | Exhibit F (19) |
| Jan 9, 2012 | 7 | Exhibit G (23) |
| Jan 9, 2012 | 8 | Exhibit H (23) |
| Jan 9, 2012 | 23 | Certificate of Consultation pursuant to LR 7.1 (3) |
| Jan 9, 2012 | 27 | Stipulation of Dismissal (4) |
| Jan 9, 2012 | 31 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A - Proposed Reply Memorandum in Support of Plaintiffs Momenta Pharmaceu (23) |
| Jan 9, 2012 | 34 | Answer to Counterclaim (5) |
| Jan 9, 2012 | 38 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (25) |
| Jan 9, 2012 | 39 | Main Document (11) |
| Jan 9, 2012 | 1 | Exhibit A (2) |
| Jan 9, 2012 | 44 | Memorandum in Support of Motion (12) |
| Jan 9, 2012 | 45 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 2 | Exhibit B (4) |
| Jan 9, 2012 | 47 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A (11) |
| Jan 9, 2012 | 50 | Notice of Appearance (2) |
| Jan 9, 2012 | 51 | Notice of Appearance (2) |
| Jan 9, 2012 | 56 | Opposition to Motion (15) |
| Jan 9, 2012 | 57 | Affidavit in Opposition to Motion (3) |
| Jan 9, 2012 | 58 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit 1 to the Declaration of Jessica Gan Lee (20) |
| Jan 9, 2012 | 2 | Exhibit 2 to the Declaration of Jessica Gan Lee (36) |
| Jan 9, 2012 | 3 | Exhibit 3 to the Declaration of Jessica Gan Lee (5) |
| Jan 9, 2012 | 4 | Exhibit 4 to the Declaration of Jessica Gan Lee (5) |
| Jan 9, 2012 | 61 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A (12) |
| Jan 9, 2012 | 2 | Text of Proposed Order (2) |
| Jan 9, 2012 | 2 | Corporate Disclosure Statement (3) |
| Jan 9, 2012 | 1 | Main Document (12) |
| Jan 9, 2012 | 1 | Exhibit A1 '886 Patent (21) |
| Jan 9, 2012 | 2 | Exhibit A2 '886 Patent (9) |
| Jan 9, 2012 | 3 | Exhibit A3 '886 Patent (9) |
| Jan 9, 2012 | 4 | Exhibit A4 '886 Patent (10) |
| Jan 9, 2012 | 5 | Exhibit A5 '886 Patent (9) |
| Jan 9, 2012 | 6 | Exhibit B1 '466 Patent (11) |
| Jan 9, 2012 | 7 | Exhibit B2 '466 Patent (7) |
| Jan 9, 2012 | 8 | Exhibit B3 '466 Patent (5) |
| Jan 9, 2012 | 9 | Exhibit C Teva's Q4 Earnings Conference Transcript (23) |
| Jan 9, 2012 | 10 | Exhibit D Teva's Q1 2010 Earnings Call (20) |
| Jan 9, 2012 | 11 | Exhibit E Teva's Press Release (3) |
| Jan 9, 2012 | 12 | Exhibit F Teva's Q2 2010 Earnings Conference Transcript (23) |
| Jan 9, 2012 | 13 | Exhibit G Teva Article (2) |
| Jan 9, 2012 | 14 | Exhibit H Teva's Q3 2010 Earnings Conference Transcript (19) |
| Jan 9, 2012 | 15 | Civil Cover Sheet (2) |
| Jan 9, 2012 | 16 | Category Form (1) |
| Jan 9, 2012 | 5 | Notice of Appearance (2) |
| Jan 9, 2012 | 6 | Notice of Appearance (2) |
| Jan 9, 2012 | 19 | Stipulation (3) |
| Jan 9, 2012 | 20 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (10) |
| Jan 9, 2012 | 21 | Memorandum in Support of Motion (12) |
| Jan 9, 2012 | 22 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (3) |
| Jan 9, 2012 | 2 | Exhibit B (43) |
| Jan 9, 2012 | 3 | Exhibit C (20) |
| Jan 9, 2012 | 4 | Exhibit D (3) |
| Jan 9, 2012 | 5 | Exhibit E (2) |
| Jan 9, 2012 | 6 | Exhibit F (19) |
| Jan 9, 2012 | 7 | Exhibit G (23) |
| Jan 9, 2012 | 8 | Exhibit H (23) |
| Jan 9, 2012 | 23 | Certificate of Consultation pursuant to LR 7.1 (3) |
| Jan 9, 2012 | 27 | Stipulation of Dismissal (4) |
| Jan 9, 2012 | 31 | Main Document (4) |
| Jan 9, 2012 | 1 | Exhibit A - Proposed Reply Memorandum in Support of Plaintiffs Momenta Pharmaceu (23) |
| Jan 9, 2012 | 34 | Answer to Counterclaim (5) |
| Jan 9, 2012 | 38 | Main Document (3) |
| Jan 9, 2012 | 1 | Exhibit A (25) |
| Jan 9, 2012 | 39 | Main Document (11) |
| Jan 9, 2012 | 1 | Exhibit A (2) |
| Jan 9, 2012 | 44 | Memorandum in Support of Motion (12) |
